GHK-Cu is a naturally occurring copper-binding tripeptide used as a reference compound in in vitro studies of extracellular matrix biology, fibroblast signaling, and copper-dependent redox chemistry. First characterized in 1973, it is studied in cell-culture systems for its interactions with copper(II) ions and its effects on gene expression at the cellular level. All work described here refers to laboratory models and is for research use only by qualified professionals.
In published characterization studies, GHK-Cu has been reported to modulate the expression of a large fraction of the genes examined in cultured human cells, including genes associated with collagen synthesis, matrix remodeling, and antioxidant defense. These observations are confined to cell-culture and biochemical assay systems.
Key specifications
- Peptide sequence: glycine-histidine-lysine (Gly-His-Lys)
- Approximate molecular weight: ~403 Da for the copper complex (C14H23CuN6O4+, 402.92); the free GHK tripeptide is ~340 Da
- Metal coordination: binds copper(II) ions
- Form: lyophilized powder for laboratory reconstitution
- Storage: store lyophilized material cold and protected from light; reconstitute with appropriate laboratory solvent for in vitro use
What is GHK-Cu at the molecular level?
GHK-Cu is a tripeptide composed of three amino acids (glycine, histidine, and lysine) that forms a stable coordination complex with copper(II) ions. Copper is bound primarily through the histidine imidazole and the amino terminus. Its small size makes it a useful model peptide for studying copper transport and peptide-metal coordination chemistry in vitro.
At physiological pH in buffered systems, GHK-Cu can form binary and ternary complexes, sometimes involving albumin or additional histidine residues. Copper participates in redox reactions relevant to the cellular pathways studied with this peptide, and the peptide portion is thought to direct these interactions in culture. Researchers studying related copper and cellular-repair chemistry may also work with glutathione as a complementary reference compound.
How is gene modulation studied in vitro?
In cultured human cells, GHK-Cu has been reported to alter the expression of a substantial proportion of the genes assayed, with a mix of up- and down-regulated transcripts. Reported pathways of interest in these datasets include:
- Collagen and elastin gene expression
- Matrix metalloproteinase regulation
- Growth factor–associated transcripts
- DNA-repair–associated genes
Cell-culture studies have reported changes in TGF-β–associated signaling and in enzymes that remodel the extracellular matrix. In fibroblast cultures, increases in basic fibroblast growth factor expression have been described, and some reports combine GHK-Cu incubation with LED light exposure to examine effects on cell viability in vitro.
What antioxidant and anti-inflammatory pathways are described in culture?
In cell-culture and biochemical systems, GHK-Cu has been studied for its interactions with oxidative-stress and inflammatory signaling pathways. Reported observations include increased antioxidant enzyme activity and modulation of inflammatory cytokine expression in exposed cultures.
- Reported modulation of TNF-associated signaling in wound-model cultures
- Reported suppression of NF-κB–associated pathway activity in vitro
- Reported changes in inflammatory enzyme expression
Some studies describe activation of the proteasome pathway and clearance of damaged proteins in cultured cells. These findings are characterization data from laboratory models and describe cellular behavior only.
How is GHK-Cu studied in fibroblast and matrix models?
GHK-Cu is frequently used in fibroblast-based assays, since fibroblasts are the primary producers of collagen in culture. Researchers typically use primary dermal fibroblasts or established lines such as NIH 3T3, grown in DMEM with 10% fetal bovine serum, with GHK-Cu tested across a range such as 1–100 μM.
A representative in vitro protocol:
- Seed 5,000–10,000 cells per well in 96-well plates
- Allow attachment for 24 hours
- Incubate with GHK-Cu for 24–72 hours
- Quantify collagen by ELISA
Proliferation is assessed by MTT or BrdU assays, and viability testing defines working concentration ranges. Matrix metalloproteinase activity (for example MMP-1 and MMP-3) is a common readout for matrix-remodeling studies, and type I and III collagen mRNA can be measured by RT-PCR. Comparative work on collagen synthesis is also discussed in the store's Sermorelin in vitro guide.
How are wound-model and angiogenesis assays designed?
In vitro wound-model assays examine how GHK-Cu affects cell migration and gap closure in cultured monolayers. Scratch assays are a common first step.
Migration readouts:
- Scratch-wound assays in cell monolayers
- Transwell chambers with chemotactic gradients
- Live-cell imaging to track movement
- Gap closure measured at 6, 12, and 24 hours
Angiogenesis readouts:
- Tube-formation assays with endothelial cells on Matrigel
- VEGF analysis in exposed cultures
- Counting of capillary-like structures
Standardized gaps are created with pipette tips or dedicated tools, and software such as ImageJ automates measurement. Co-cultures that combine fibroblasts with keratinocytes or endothelial cells provide more complex tissue models, with cell-to-cell signaling assessed via cytokine analysis.
How is GHK-Cu compared against other peptides in research?
Comparative studies help define what distinguishes GHK-Cu from related compounds. Controls commonly include GHK without copper (see GHK vs GHK-Cu: the free tripeptide and its copper complex), single amino acids, and scrambled sequences. Dose-response testing across roughly 0.1–1000 μM and IC50 determination help define working ranges.
Common design elements:
- Positive controls using characterized growth factors
- Vehicle-only negative controls
- Scrambled peptides for specificity checks
- Time-matched conditions
Mechanistic studies apply pathway inhibitors before peptide exposure to probe specific targets, with Western blots confirming activation or suppression. Multi-parametric assays, flow cytometry, and high-content imaging allow several readouts to be collected at once.
What related peptides are studied alongside GHK-Cu?
Researchers studying receptor- and ligand-driven cellular signaling sometimes examine GHK-Cu alongside other reference peptides. For example, Sermorelin, a growth-hormone-releasing-hormone analog, is studied in receptor-binding and cellular-response assays, and the broader pituitary peptide collection is used in related in vitro work. Comparative study designs treat each compound strictly as a laboratory reference material characterized by its molecular interactions, not by any effect in a living subject.
GHK-Cu is also the largest component by mass (50 mg per vial) of the catalog's co-formulated GLOW peptide blend and KLOW peptide blend, where it is combined with BPC-157 and TB-500 (and, in KLOW, KPV); the copper complex is what gives both blends their blue colour.
Related research guides
- AHK-Cu vs GHK-Cu: two copper-binding tripeptides compared
- GHK-Cu name variants: one compound
- Sourcing GHK-Cu as a research material: COA, copper content and purity
- GHK-Cu and copper coordination chemistry in vitro
- GLOW peptide blend: components and in-vitro dermal research profile
- KLOW peptide blend: components and in-vitro research profile
